Helix BioPharma(TSE:HBP)
CA$0.850.00 (0.00%)
TSE:HBP
Helix BioPharma financials statements
CA$0.85
At close:0.00 (0.00%)
Want to see TSE:HBP full AI Analyst Report?
Helix BioPharma (HBP) Financial Statements
32 Followers
Helix BioPharma Financial Overview
Helix BioPharma's market cap is currently C$64.92M. The company's EPS TTM is C$-0.04; its P/E ratio is -19.32; Helix BioPharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jul 26 | Jul 25 | Jul 24 | Jul 23 | Oct 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -4.00K | C$ -10.00K | C$ -14.00K | C$ -13.00K | C$ -12.00K |
| Operating Income | C$ -3.64M | C$ -5.42M | C$ -9.37M | C$ -6.28M | C$ -6.54M |
| EBITDA | C$ -3.65M | C$ -5.21M | C$ -9.38M | C$ -6.31M | C$ -6.03M |
| Net Income | C$ -3.35M | C$ -5.21M | C$ -9.26M | C$ -6.29M | C$ -6.08M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 804.00K | C$ 65.00K | C$ 1.08M | C$ 808.00K | C$ 3.25M |
| Total Assets | C$ 19.38M | C$ 18.80M | C$ 1.49M | C$ 1.03M | C$ 3.73M |
| Total Debt | C$ 4.16M | C$ 336.00K | C$ 0.00 | C$ 0.00 | C$ 2.47M |
| Net Debt | C$ 3.35M | C$ 271.00K | C$ -1.08M | C$ -808.00K | C$ -784.00K |
| Total Liabilities | C$ 5.17M | C$ 3.22M | C$ 1.58M | C$ 1.87M | C$ 3.41M |
| Stockholders' Equity | C$ 14.21M | C$ 15.59M | C$ -90.00K | C$ -844.00K | C$ 319.00K |
| Cash Flow | |||||
| Free Cash Flow | C$ -4.32M | C$ -3.83M | C$ -5.23M | C$ -5.54M | C$ -6.51M |
| Operating Cash Flow | C$ -4.32M | C$ -3.83M | C$ -5.22M | C$ -5.53M | C$ -6.51M |
| Investing Cash Flow | C$ 0.00 | C$ 17.00K | C$ -14.00K | C$ -5.00K | C$ 0.00 |
| Financing Cash Flow | C$ 5.05M | C$ 2.80M | C$ 5.51M | C$ 3.09M | C$ 6.21M |
Currency in CAD
